VXRT logo

VXRT
Vaxart Inc

74,732
Mkt Cap
$135.88M
Volume
228,509.00
52W High
$0.8449
52W Low
$0.2606
PE Ratio
-2.55
VXRT Fundamentals
Price
$0.566
Prev Close
$0.5649
Open
$0.57
50D MA
$0.4995
Beta
1.34
Avg. Volume
1.45M
EPS (Annual)
-$0.3312
P/B
4.84
Rev/Employee
$249,565.22
$105.40
Loading...
Loading...
Vaxart, Inc. is a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). The company was founded by Sean Tucker in March 2004 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
115

Frequently Asked Questions

What is Market Cap of Vaxart Inc?
What is the 52-week high for Vaxart Inc?
What is the 52-week low for Vaxart Inc?
What is Vaxart Inc stock price today?
What was Vaxart Inc stock price yesterday?
What is the PE ratio of Vaxart Inc?
What is the Price-to-Book ratio of Vaxart Inc?
What is the 50-day moving average of Vaxart Inc?
How many employees does Vaxart Inc have?

Latest VXRT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.